Robert L. Murphy is the John Philip Phair Professor of Infectious Diseases and Professor of Biomedical Engineering at Northwestern University. He directs the Institute for Global Health within the Institute for Public Health and Medicine. His roles include leadership in global health research, infectious disease management, and biomedical engineering. Murphy holds appointments in the Feinberg School of Medicine and McCormick School of Engineering. Education: MD from Loyola University Stritch School of Medicine (1978), Fellowship, Residency, and Board Certification in Internal Medicine at Northwestern University (1981–1984). Research focuses on HIV/AIDS, viral hepatitis, antiviral therapies, and global health disparities. He leads projects in Nigeria, Mali, and other regions, addressing liver fibrosis in HIV/HBV co-infection, cervical cancer in HIV-positive women, and SARS-CoV-2 diagnostics. His work emphasizes point-of-care technologies and epigenetic biomarkers for cancer and liver disease. Publications span over 40 years, with recent emphasis on Omicron variant dynamics, HPV screening in resource-limited settings, and microbiome impacts of antiretroviral therapy. He collaborates globally, co-leading studies on tuberculosis treatment and HIV/drug resistance patterns. Grants and collaborations include the BRAINS faculty development program in Africa, the Test Us Bank (TUB) biorepository for SARS-CoV-2 samples, and partnerships with institutions like the University of Lagos and the Robert H. Lurie Comprehensive Cancer Center.









